Abstract

Myocardial ischemia activates AMP kinase (AMPK), which modulates electrophysiology. A spontaneous point mutation from Val199→Ile in the AMPK γ3 subunit of Ossabaw swine impairs AMPK function. We hypothesized that ischemia would elicit greater electrocardiographic ST segment elevation (STE) in AMPK mutant compared to non‐mutant swine. Ischemia induced by balloon occlusion of the circumflex artery was verified by angiography. AMPK mutants showed significant STE within 3 min of ischemia, while non‐mutants showed an STE of ~2mm during 15 min of ischemia. Percent survival to the STE criterion was greater in non‐mutants vs. mutants (p<0.05). Intracoronary infusion of the AMPK activator AICAR (0.5 mM) for 10 min before coronary occlusion reduced profound STE in AMPK mutants, but completely prevented STE in non‐mutants. Percent survival to the STE criterion again was greater in non‐mutants vs. mutants during ischemia. Compound C, an inhibitor of AMPK, trended to decrease time to reach STE criterion compared to AICAR. Metabolic syndrome induced by hypercaloric atherogenic diet was similar in mutants and non‐mutants. Mutants reached the STE criterion in 4 min, but the non‐mutants did not in the 15 min occlusion, thus showing a striking cardiac phenotype. In conclusion, a functional cardiac AMPK and pharmacological AMPK activation decrease ischemia‐induced ST segment elevation. (Support: NIH HL062552)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call